Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

The girl was diagnosed with stage 2 of the disease, a status that meant her own immune system was making at least two types ...

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by ...

Non-adherence to at least one prescribed antidiabetic drug is highly common among patients with type 2 diabetes and rises ...

Genetic screening can mean that people at risk of type 1 diabetes get earlier treatment and better outcomes This article is ...

While nearly 40 million people in the US suffer from diabetes, some 8.7 million of them don’t even know they have the ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

The NHS has issued a cautionary note on its website for those taking metformin, particularly those who have been on the ...

KARACHI: BF Biosciences Limited has launched Zeptide® (Tirzepatide), an advanced treatment for Type 2 diabetes and obesity, marking a major milestone in Pakistan’s biopharmaceutical sector. In a ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...

At its core, diabetes is a disease that occurs when your blood glucose, also called blood sugar, is too high. Glucose is our ...